Central Bancorp (CEBK)

30.50 +0.00  +0.00%  May 25, 11:00PM Go Pro
Watch this stock

Central Bancorp R&D Expense

Get Interactive Chart for


of


Select a metric
 
Date range: to
<Embed Chart> Pro Save as Image Pro Data Export
Attention OK

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

CEBK News

$CEBK filed latest Quarterly Report http://stks.co/17NT
about 196 days ago by MarketBrief

Recent Quotes

Symbol Price Chg Chg % Market Cap
CEBK 30.50 +0.00 +0.00% 51.24M
CEA 14.45 -0.10 -0.69% 2.769B
COGO 1.89 +0.02 +1.07%
COG 34.77 -0.30 -0.86% 7.282B
COF 51.13 -0.59 -1.14% 29.66B
CODI 13.12 -0.03 -0.23% 633.70M
CODE 10.81 -0.07 -0.64% 647.74M
COCO 2.82 +0.26 +10.16% 239.39M
COBR 4.45 -0.15 -3.26% 29.41M
CIG 17.22 +0.06 +0.35% 14.69B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close